Key Takeaways
- Shares declined 11.37% Thursday, closing at $688.80, then rebounded 1.50% to $699.10 in extended-hours trading.
- The company revealed plans for a 240,000-square-foot production facility in Greensboro, NC, purchased from Qorvo, with operations expected by mid-2028.
- NVIDIA has been identified as a client through existing strategic partnerships connected to the facility expansion.
- Lumentum’s previous quarter showed EPS of $1.67, surpassing the $1.41 forecast, while revenue climbed 65.5% year-over-year to $665.5M.
- Price targets vary significantly — BNP Paribas projects $1,040 while the average analyst target is $575.06; company insiders offloaded approximately $38.9M in shares recently.
Shares of Lumentum Holdings (LITE) experienced significant turbulence Thursday, plummeting 11.37% to settle at $688.80. Trading volume reached approximately 6.18 million shares — roughly 4% higher than typical daily activity.
However, the stock regained ground during after-hours trading. Shares climbed 1.50% to $699.10 after the company disclosed details about a significant domestic manufacturing investment.
Lumentum revealed it had purchased a 240,000-square-foot manufacturing location in Greensboro, North Carolina, from semiconductor manufacturer Qorvo. The facility will specialize in producing indium phosphide optical components, including continuous wave lasers and ultra-high-power laser systems utilizing 6-inch InP wafer technology.
The facility aims to reach full production capacity by mid-2028. CEO Michael Hurlston noted that clients are “constructing the foundation for the next generation of computational technology.”
NVIDIA was named as a customer through existing strategic arrangements related to this manufacturing expansion. Debora Shoquist, NVIDIA’s Executive Vice President of Operations, commented that the development “enhances supply chain reliability and enables us to address expanding infrastructure requirements with assurance.”
The after-hours recovery indicates investors interpreted the decline as an attractive entry point rather than a signal of underlying business challenges.
Impressive Quarterly Performance and Upgraded Outlook
Lumentum’s latest financial results provided substantial reasons for investor confidence. The company delivered earnings per share of $1.67, exceeding analyst expectations of $1.41 by $0.26.
Quarterly revenue reached $665.5 million — representing a 65.5% increase compared to the same period last year and surpassing the projected $646.74 million. Management issued Q3 2026 EPS guidance between $2.15 and $2.35.
Despite these positive developments, the stock has retreated from its 52-week peak of $808.80. Nevertheless, it continues trading 84% above its 52-week low of $45.66, with an impressive 941.90% gain over the trailing twelve months.
The current price remains substantially above both the 50-day moving average of $567.66 and the 200-day moving average of $363.11 — demonstrating sustained upward momentum.
Divergent Analyst Perspectives
Wall Street analysts maintain widely varying outlooks on the stock. BNP Paribas maintains the most bullish stance with a $1,040 price target, suggesting approximately 47% potential upside from present levels.
Morgan Stanley kept its Equal-Weight rating while increasing its target from $520 to $595. Mizuho maintains an “outperform” rating alongside a $645 price objective.
The consensus among 19 analysts reflects a “Moderate Buy” recommendation with an average target price of $575.06 — notably beneath the stock’s current trading level.
Regarding insider activity, company executives disposed of approximately 65,775 shares valued at roughly $38.9 million during the previous 90-day period. Institutional investors control about 94% of outstanding shares.
LITE’s Relative Strength Index registered 52.34 entering Friday’s session, while the company’s market capitalization stood near $49.18 billion.
